Follow
Be'Eri Niego
Be'Eri Niego
Research Fellow, NanoBiotechnology Research Group
Verified email at monash.edu
Title
Cited by
Cited by
Year
Shear-dependent platelet aggregation: mechanisms and therapeutic opportunities
A Rana, E Westein, B Niego, CE Hagemeyer
Frontiers in cardiovascular medicine 6, 141, 2019
1522019
Tissue‐type plasminogen activator requires a co‐receptor to enhance NMDA receptor function
AL Samson, ST Nevin, D Croucher, B Niego, PB Daniel, TW Weiss, ...
Journal of neurochemistry 107 (4), 1091-1101, 2008
1432008
t-PA–specific modulation of a human blood-brain barrier model involves plasmin-mediated activation of the Rho kinase pathway in astrocytes
B Niego, R Freeman, TB Puschmann, AM Turnley, RL Medcalf
Blood, The Journal of the American Society of Hematology 119 (20), 4752-4761, 2012
1132012
Plasmin-dependent modulation of the blood–brain barrier: a major consideration during tPA-induced thrombolysis?
B Niego, RL Medcalf
Journal of Cerebral Blood Flow & Metabolism 34 (8), 1283-1296, 2014
1072014
Oncostatin M is a neuroprotective cytokine that inhibits excitotoxic injury in vitro and in vivo
TW Weiss, AL Samson, B Niego, PB Daniel, RL Medcalf, TW Weiss, ...
The FASEB journal 20 (13), 2369-2371, 2006
542006
A nonfibrin macromolecular cofactor for tPA-mediated plasmin generation following cellular injury
AL Samson, RJ Borg, B Niego, CHY Wong, PJ Crack, T Yongqing, ...
Blood, The Journal of the American Society of Hematology 114 (9), 1937-1946, 2009
522009
Selective inhibition of brain endothelial Rho-kinase-2 provides optimal protection of an in vitro blood-brain barrier from tissue-type plasminogen activator and plasmin
B Niego, N Lee, P Larsson, TM De Silva, AEL Au, F McCutcheon, ...
PLoS One 12 (5), e0177332, 2017
432017
Fabrication of complex PDMS microfluidic structures and embedded functional substrates by one-step injection moulding
C Szydzik, B Niego, G Dalzell, M Knoerzer, F Ball, WS Nesbitt, RL Medcalf, ...
RSC advances 6 (91), 87988-87994, 2016
362016
Valproic acid selectively increases vascular endothelial tissue‐type plasminogen activator production and reduces thrombus formation in the mouse
P Larsson, I Alwis, B Niego, M Sashindranath, P Fogelstrand, MCL Wu, ...
Journal of thrombosis and haemostasis 14 (12), 2496-2508, 2016
352016
t-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions
R Freeman, DR Croucher, LO Pedersen, RL Medcalf
brain research 1565, 63-73, 2014
272014
t-PA suppresses the immune response and aggravates neurological deficit in a murine model of ischemic stroke
DF Draxler, F Lee, H Ho, CB Keragala, RL Medcalf, B Niego
Frontiers in immunology 10, 430334, 2019
242019
Novel thrombolytic drug based on thrombin cleavable microplasminogen coupled to a single‐chain antibody specific for activated GPIIb/IIIa
T Bonnard, Z Tennant, BE Niego, R Kanojia, K Alt, S Jagdale, LS Law, ...
Journal of the American Heart Association 6 (2), e004535, 2017
242017
Thrombin-induced activation of astrocytes in mixed rat hippocampal cultures is inhibited by soluble thrombomodulin
B Niego, AL Samson, KU Petersen, RL Medcalf
Brain research 1381, 38-51, 2011
242011
Desmoteplase-mediated plasminogen activation and clot lysis are inhibited by the lysine analogue tranexamic acid
B Niego, A Horvath, PB Coughlin, MK Pugsley, RL Medcalf
Blood Coagulation & Fibrinolysis 19 (4), 322-324, 2008
232008
Applications of nanotechnology in the diagnosis and therapy of stroke
LM Landowski, B Niego, BA Sutherland, CE Hagemeyer, DW Howells
Seminars in thrombosis and hemostasis 46 (05), 592-605, 2020
222020
Effective treatment of mouse metastatic prostate cancer by low electric field enhanced chemotherapy
A Plotnikov, B Niego, R Ophir, R Korenstein, Y Keisari
The Prostate 66 (15), 1620-1630, 2006
222006
Bioresponsive polyphenol-based nanoparticles as thrombolytic drug carriers
H Yu, JS Palazzolo, J Zhou, Y Hu, B Niego, S Pan, Y Ju, TY Wang, Z Lin, ...
ACS Applied Materials & Interfaces 14 (3), 3740-3751, 2022
182022
Two conserved regions within the tissue‐type plasminogen activator gene promoter mediate regulation by brain‐derived neurotrophic factor
PB Daniel, W Lux, AL Samson, WD Schleuning, B Niego, TW Weiss, ...
The FEBS journal 274 (9), 2411-2423, 2007
182007
Tranexamic acid modulates the cellular immune profile after traumatic brain injury in mice without hyperfibrinolysis
DF Draxler, M Daglas, A Fernando, G Hanafi, F McCutcheon, H Ho, ...
Journal of Thrombosis and Haemostasis 17 (12), 2174-2187, 2019
162019
Fibrinolysis and the immune response in trauma
RL Medcalf, CB Keragala, DF Draxler
Seminars in Thrombosis and Hemostasis 46 (02), 176-182, 2020
152020
The system can't perform the operation now. Try again later.
Articles 1–20